Ortolani, Silvia
 Distribuzione geografica
Continente #
EU - Europa 627
NA - Nord America 626
AS - Asia 281
SA - Sud America 4
AF - Africa 1
OC - Oceania 1
Totale 1.540
Nazione #
US - Stati Uniti d'America 625
GB - Regno Unito 251
CN - Cina 237
SE - Svezia 90
IT - Italia 64
DE - Germania 55
IE - Irlanda 54
FR - Francia 43
RU - Federazione Russa 28
FI - Finlandia 17
SG - Singapore 15
JP - Giappone 11
UA - Ucraina 10
AT - Austria 5
IN - India 4
IR - Iran 4
TR - Turchia 4
BE - Belgio 3
NL - Olanda 3
BR - Brasile 2
ES - Italia 2
KR - Corea 2
PE - Perù 2
BD - Bangladesh 1
CA - Canada 1
CH - Svizzera 1
IM - Isola di Man 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 1.540
Città #
Southend 231
Chandler 164
Woodbridge 70
Beijing 61
Ann Arbor 55
Dublin 54
Ashburn 35
Jacksonville 35
Shenyang 25
Wilmington 22
Houston 21
Jinan 21
Lancaster 17
Lawrence 17
Princeton 17
Verona 15
Nanjing 14
New York 14
Bologna 12
Singapore 12
Tianjin 11
Tokyo 10
Nanchang 9
Zhengzhou 8
Haikou 7
Redwood City 7
Taiyuan 7
Changsha 6
Ningbo 6
Taizhou 6
Düsseldorf 5
Hebei 5
Kent 5
Lanzhou 5
Seattle 5
Jiaxing 4
Milan 4
Sindelfingen 4
Boardman 3
Brussels 3
Dallas 3
Falls Church 3
Genova 3
Hangzhou 3
Norwalk 3
Fairfield 2
Guangzhou 2
Lima 2
Los Angeles 2
Riva 2
Seoul 2
São Paulo 2
Vic 2
Washington 2
Zanjan 2
Adliswil 1
Andover 1
Auckland 1
Bangkok 1
Bolzano 1
Brescia 1
Cascina 1
Centro 1
Chengdu 1
Clearwater 1
Dalian 1
Dearborn 1
Delhi 1
Dhaka 1
Dolo 1
Douglas 1
Fazal 1
Fuzhou 1
Groningen 1
Helsinki 1
Kochi 1
Kyoto 1
Landshut 1
Lappeenranta 1
Las Vegas 1
Nürnberg 1
Pisa 1
Reggiolo 1
Reno 1
San Francisco 1
San Jose 1
Tashkent 1
Torino 1
Toronto 1
Trento 1
Treviso 1
Viterbo 1
Wuhan 1
Totale 1.105
Nome #
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 115
Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay 110
Perfusion Changes in Liver Metastases (LM) from Pancreatic Neuroendocrine Tumors (PanNETs) during Everolimus (E) Treatment: Update of Perfusion CT (P-CT) Study 109
Tumor Perfusion Changes During Everolimus (E) Treatment: Preliminary Results from Perfusion-CT (P-CT) Study 107
Role of Combined Ga-68-DOTATOC and F-18-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors Implications for Managing Surgical Decisions 104
Tumor Perfusion Changes During Everolimus (E) Treatment: Preliminary Results from Perfusion-CT (P-CT) Study 99
Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? 99
Tumor seeding after percutaneous US-guided FNA of solid pancreatic neoplasms 98
Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage 96
ESGAR 2016 Book of Abstracts 90
Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment 89
Prognostication and response assessment in liver and pancreatic tumors: The new imaging 87
Digital Subtraction of Magnetic Resonance Images Improves Detection and Characterization of Pancreatic Neuroendocrine Neoplasms 83
Intravoxel incoherent motion diffusion-weighted MR imaging of solid pancreatic masses: reliability and usefulness for characterization 82
Pancreatic neuroendocrine neoplasms: MRI features and correlation with their histological grade 77
Histogram analysis of ADC maps: assessment of intra-tumoral heterogeneity and correlation with the biological behavior of pancreatic neuroendocrine neoplasms 70
Suppression of mTOR pathway in solid tumors: lessons learned from clinical experience in renal cell carcinoma and neuroendocrine tumors and new perspectives 56
Totale 1.571
Categoria #
all - tutte 4.982
article - articoli 2.995
book - libri 0
conference - conferenze 1.987
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.964


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020143 0 0 2 6 15 17 31 1 8 11 34 18
2020/2021132 26 26 6 22 17 15 0 0 8 0 12 0
2021/2022169 13 53 0 14 17 7 6 7 6 2 12 32
2022/2023403 20 57 39 82 20 102 3 20 44 2 10 4
2023/2024158 7 14 11 14 24 29 1 15 2 11 24 6
2024/202556 16 25 15 0 0 0 0 0 0 0 0 0
Totale 1.571